-
[one week countdown to registration] pharmacon 2019's guests' big exposure - a boutique R & D forum that chemical companies can't miss
Time of Update: 2019-09-06
Pharmacon 2019, the Fifth China International Chemical Research and development forum, will be held on September 24-25 in Regal global East Asia Hotel, Shanghai Nearly 50 events will be set up for ann
-
Following the direction of pharmaceutical purchasing reform, the price of consumables will be reduced by more than 50
Time of Update: 2019-08-08
[trends of pharmaceutical network industry] high value medical consumables refer to those that directly affect human body, have strict requirements for safety, have large clinical use, relatively high
-
In the near future, who are the top five pharmaceutical companies applying for the number of generic drugs
Time of Update: 2019-08-02
[industry trends of pharmaceutical network] at present, with the continuous implementation of bidding and procurement policies in various regions, pharmaceutical companies are no longer in the "wait-a
-
The complementary policy of Chinese and Western medicine was promoted, and 6 pharmaceutical stocks rose by more than 1
Time of Update: 2019-07-25
[pharmaceutical network industry trends] affected by the promotion of complementary policies between Chinese and Western medicine, pharmaceutical stocks are generally better A few days ago, according
-
6 in case of shortage of drugs, the original online price shall be cancelled and included in the direct online drug catalog
Time of Update: 2019-05-06
Recently, Hunan provincial medicine centralized purchase network released the notice of "Listing 6 drugs of aminomethylbenzoic acid tablets directly on the Internet" According to the notice, as there
-
Traditional Chinese medicine injection with unknown safety will face "life and death
Time of Update: 2019-03-27
[China Pharmaceutical network industry trends] recently, the state health insurance bureau released the work plan for the adjustment of the national medical insurance drug catalog in 2019 (Draft for c
-
Does "4 + 7" price selection change the pattern of Fujian
Time of Update: 2019-03-13
Medical network, March 13 Sanming had the experience and foundation of "volume for price" before, and it is also the star city of medical reform The landing of 4 + 7 price may, to some extent, open th
-
Perspective Guangxi medicine: does Shenzhen GPO price follow
Time of Update: 2019-02-22
Recently, there are many and miscellaneous news about drug purchase in Guangxi Shenzhen GPO and Wuzhou officially signed a regional procurement alliance, and the first batch of varieties (438 varietie
-
Hengrui pharmaceutical's revenue in 2018 was 17.418 billion yuan, with a year-on-year increase of over 50% in R & D
Time of Update: 2019-02-18
[China Pharmaceutical network enterprise news] on February 16, Hengrui pharmaceutical announced its 2018 annual report Data shows that in 2018, the company realized revenue of 17.418 billion yuan, a y
-
Newest! Suspension of export of Huahai 2 sartan APIs to Europe
Time of Update: 2019-01-16
New progress has been made in the detection of NDEA impurities in irbesartan and losartan potassium APIs of Huahai pharmaceutical On January 15, Huahai Pharmaceutical Co., Ltd announced that due to th
-
Cost rise, factory price rise, retail price rise of some household common drugs
Time of Update: 2019-01-15
Recently, the weather is cold and more people have a cold Many people will go to the pharmacy to buy some medicine to treat the cold and fever Some people found that the price of some common cold drug
-
40th anniversary of reform and opening up
Time of Update: 2018-12-20
On December 18, the conference to celebrate the 40th anniversary of reform and opening up was held in Beijing 40 years of hard work, 40 years of hard work, 40 years of hard work On the 40th anniversar
-
The 40th anniversary of reform and opening up: the revenue of pharmaceutical industry increased by 346 times to 2.53 trillion yuan
Time of Update: 2018-12-19
On December 18, the conference to celebrate the 40th anniversary of reform and opening up was held in Beijing 40 years of hard work, 40 years of hard work, 40 years of hard work On the 40th anniversar
-
Yaoming biological Co., Ltd. is authorized to use wuxibody (TM) to develop five double antibodies with us $450 million
Time of Update: 2018-12-11
December 11, 2018 / Meitong news agency / -- Wuxi biology, the world's leading open biopharmaceutical technology platform company, 2269 HK) announced today that it will further deepen strategic cooper
-
Fosun Pharmaceutical subsidiary has obtained the exclusive sales license of neurotoxin rt002
Time of Update: 2018-12-06
On December 5, Fosun Pharmaceutical announced that its holding subsidiary Shanghai Fosun Pharmaceutical Industry Development Co., Ltd was licensed by revancetherapeutics, Inc to exclusively use, impor
